Back
CHL
Camplify Holdings Limited
🇦🇺 ASX
🛤️ TRANSPORTATION INFRASTRUCTURE
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
-17.18%
Annual Growth
4 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
22
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Camplify Holdings Ltd. operates in the RV rental market. The Company’s platform delivers a seamless and transparent experience for consumers (potential RV hirers) to connect with RV owners and SMEs with a fleet of RVs. Its segments include Hire, Membership and Other. The company has a global family of RV rental marketplace brands. The brands include Camplify, PaulCamper, and MyWay. The firm provides a range of caravans, motorhomes, camper trailers and campervans for hire via the respective platforms. MyWay provides insurance solutions to RV marketplace customers, and PaulCamper is a peer-to-peer van-sharing platform connecting van owners with travelers. The company operates in seven key markets, such as Australia, New Zealand, the United Kingdom, Spain, Germany, the Netherlands, and Austria. Its subsidiaries include Camplify Co (Australia) Pty Ltd, Camplify Co (NZ) Limited, and others.
📈 Performance
Price History
-72.54%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.39
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in CHL
22
📊 Total Capital Earnings
$26K
🔃 Average investment frequency
38 weeks
💵 Average investment amount
$1,185
⏰ Last time a customer invested in CHL
36 days
CHL investor breakdown
💵 Income of investors
More than 200k
6%
150k - 200k
100k - 150k
20%
50k - 100k
31%
Less than 50k
34%
👶 Age of investors
18 - 25
9%
26 - 34
45%
35 - 90
45%
🙋 Legal gender of investors
Female
55%
Male
45%
Pearlers who invest in CHL also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
9.30%
📊 Share price
$110.93 AUD
🇦🇺 AUSTRALIA
💸 FINANCIALS
🧱 MATERIALS
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
7.43%
📊 Share price
$72.96 AUD
⛳️ DIVERSIFIED
🌏 GLOBAL
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
17.25%
📊 Share price
$147.70 AUD
🌏 GLOBAL
⛳️ DIVERSIFIED
🤖 TECHNOLOGY
📈 HIGH PRICE GROWTH
IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
🙌 Performance (5Yr p.a)
22.52%
📊 Share price
$66.03 AUD
📈 HIGH PRICE GROWTH
🇺🇸 UNITED STATES
NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.
🙌 Performance (5Yr p.a)
21.63%
📊 Share price
$53.18 AUD
📈 HIGH PRICE GROWTH
🤖 TECHNOLOGY
🇺🇸 UNITED STATES
Want more shares? Try these...
Chimeric Therapeutics Ltd. is a clinical stage cell therapy company, which engages in the development and commercialization of cell therapies in oncology. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-01-18. Its diversified portfolio includes first-in-class autologous CAR T cell therapies and allogeneic natural killer (NK) cell therapies. Its assets are being developed across multiple different disease areas in oncology with four clinical stage programs. Its pipeline includes CHM CDH17, CHM CLTX and CHM CORE NK platform. CHM CDH17 is a third-generation CDH17 CAR T, which is in phase I/II clinical trial in gastrointestinal and neuroendocrine tumors. CHM CORE-NK is a clinically validated NK cell platform in phase IB clinical trials investigating CORE-NK in combination regimens. CHM CLTX is a novel CAR-T therapy developed for the treatment of patients with solid tumors. CLTX CAR T is in phase IB clinical trial in recurrent/progressive glioblastoma. The company is also building a Cell therapy portfolio.
📊 Share price
$0.00 AUD
🧬 BIOTECHNOLOGY
